| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anıl Alp, Melike Karaçam Doğan, Elçin Özçelik Eroğlu, Mevhibe İrem Yildiz, Şeref Can Gürel, Suzan Öze. Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556940. |
fever; in addition to general medical conditions such as infection, malignancy, connective tissue diseases, drug treatments, malignant hyperthermia, convulsions, it can also occur due to conditions such as neuroleptic malignant syndrome (nms), serotonin syndrome, catatonia, malignant catatonia, which are frequently encountered in psychiatry clinics. |
2024-04-01 |
2024-04-03 |
Not clear |
| Loulwa Maktabi, Denver Shipman, Justin P Reiner. Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology. The mental health clinician. vol 14. issue 1. 2024-02-05. PMID:38312440. |
serotonin syndrome and neuroleptic malignant syndrome: a case report of intersecting symptomatology. |
2024-02-05 |
2024-02-07 |
Not clear |
| Loulwa Maktabi, Denver Shipman, Justin P Reiner. Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology. The mental health clinician. vol 14. issue 1. 2024-02-05. PMID:38312440. |
serotonin syndrome and neuroleptic malignant syndrome are caused by 2 distinct pathologies; however, the clinical presentation associated with both syndromes share many features. |
2024-02-05 |
2024-02-07 |
Not clear |
| Adela G Buciuc, Paula Traugott, Carlos R Dange. An Unusual Presentation of Serotonin Syndrome and Subsequent Catatonia in a Patient With a Family History of Huntington's Disease. Cureus. vol 15. issue 9. 2023-09-18. PMID:37720123. |
neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) represent serious life-threatening conditions that share phenotypic and pathophysiologic features due to intricate interactions between the dopaminergic and serotoninergic systems. |
2023-09-18 |
2023-10-07 |
Not clear |
| Tobias Hölle, Jan C Purrucker, Benedict Morath, Markus A Weigand, Felix C F Schmit. [Central anticholinergic, neuroleptic malignant and serotonin syndromes]. Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift. vol 26. issue 3. 2023-05-30. PMID:37251531. |
alkaloids, such as atropine can trigger a central anticholinergic syndrome, opioids can promote the occurrence of serotonin syndrome and the administration of a neuroleptic can lead to neuroleptic malignant syndrome. |
2023-05-30 |
2023-08-14 |
Not clear |
| Tobias Hölle, Jan C Purrucker, Benedict Morath, Markus A Weigand, Felix C F Schmit. [Central anticholinergic, neuroleptic malignant and serotonin syndromes]. Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift. vol 26. issue 3. 2023-05-30. PMID:37251531. |
the central anticholinergic syndrome is the fastest to appear, usually taking just a few of hours from trigger to clinical signs, serotonin syndrome takes several hours up to 1 day to show and neuroleptic malignant syndrome usually takes days. |
2023-05-30 |
2023-08-14 |
Not clear |
| Mohammad Abu-Abaa, Dhay Bahadli, Osamah Abdulhussein, Ali Abdulsahib, Daniel Landa. Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report. Cureus. vol 15. issue 1. 2023-02-28. PMID:36852358. |
cefepime-induced neurotoxicity can be confused with neuroleptic malignant syndrome, catatonia and serotonin syndrome: a case report. |
2023-02-28 |
2023-08-14 |
Not clear |
| Mohammad Abu-Abaa, Dhay Bahadli, Osamah Abdulhussein, Ali Abdulsahib, Daniel Landa. Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report. Cureus. vol 15. issue 1. 2023-02-28. PMID:36852358. |
although the diagnosis of serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) was suggested initially, the clinical picture was more compatible with cin. |
2023-02-28 |
2023-08-14 |
Not clear |
| Tobias Hölle, Jan C Purrucker, Benedict Morath, Markus A Weigand, Felix C F Schmit. [Central anticholinergic, neuroleptic malignant and serotonin syndromes : Important differential diagnoses in postoperative impairment of consciousness]. Die Anaesthesiologie. 2023-02-17. PMID:36799968. |
alkaloids, such as atropine can trigger a central anticholinergic syndrome, opioids can promote the occurrence of serotonin syndrome and the administration of a neuroleptic can lead to neuroleptic malignant syndrome. |
2023-02-17 |
2023-08-14 |
Not clear |
| Tobias Hölle, Jan C Purrucker, Benedict Morath, Markus A Weigand, Felix C F Schmit. [Central anticholinergic, neuroleptic malignant and serotonin syndromes : Important differential diagnoses in postoperative impairment of consciousness]. Die Anaesthesiologie. 2023-02-17. PMID:36799968. |
the central anticholinergic syndrome is the fastest to appear, usually taking just a few of hours from trigger to clinical signs, serotonin syndrome takes several hours up to 1 day to show and neuroleptic malignant syndrome usually takes days. |
2023-02-17 |
2023-08-14 |
Not clear |
| Takahiko Nagamin. Neuroleptic Malignant Syndrome or Serotonin Syndrome? Psychiatria Danubina. vol 34. issue 3. 2022-10-18. PMID:36256997. |
neuroleptic malignant syndrome or serotonin syndrome? |
2022-10-18 |
2023-08-14 |
Not clear |
| Michael Horseman, Ladan Panahi, George Udeani, Andrew S Tenpas, Rene Verduzco, Pooja H Patel, Daniela Z Bazan, Andrea Mora, Nephy Samuel, Anne-Cecile Mingle, Lisa R Leon, Joseph Varon, Salim Suran. Drug-Induced Hyperthermia Review. Cureus. vol 14. issue 7. 2022-08-30. PMID:36039261. |
the purpose of this article is to review the current literature and compare exertional heat stroke (ehs) to three of the most widely studied drug-induced hyperthermic syndromes: malignant hyperthermia (mh), neuroleptic malignant syndrome (nms), and serotonin syndrome (ss). drugs and drug classes that have been implicated in these conditions include amphetamines, diuretics, cocaine, antipsychotics, metoclopramide, selective serotonin reuptake inhibitors (ssris), tricyclic antidepressants (tcas), and many more. |
2022-08-30 |
2023-08-14 |
Not clear |
| Rachel Gray, Arnold Moore Iii, Fiona Berry, Farzana Afroze, Divya Cherukupall. Serotonin Syndrome after PACU Administration of Tramadol and Meperidine. Turkish journal of anaesthesiology and reanimation. vol 50. issue 4. 2022-08-18. PMID:35979980. |
serotonin syndrome, malignant hyperthermia, and neuroleptic malignant syndrome are life-threatening conditions with similar clinical presentations, all of which may occur in post-operative patients. |
2022-08-18 |
2023-08-14 |
Not clear |
| Tana Debeljak, Blanka Kores Plesniča. Distinguishing between Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: An Overview with a Case Report. Psychiatria Danubina. vol 33. issue Suppl 4. 2022-03-30. PMID:35354191. |
distinguishing between neuroleptic malignant syndrome and serotonin syndrome in polypharmacy: an overview with a case report. |
2022-03-30 |
2023-08-13 |
Not clear |
| Ryuichi Ohta, Chiaki San. Serotonin Syndrome Triggered by Overuse of Caffeine and Complicated With Neuroleptic Malignant Syndrome: A Case Report. Cureus. vol 14. issue 2. 2022-03-29. PMID:35345760. |
serotonin syndrome triggered by overuse of caffeine and complicated with neuroleptic malignant syndrome: a case report. |
2022-03-29 |
2023-08-13 |
Not clear |
| Ryuichi Ohta, Chiaki San. Serotonin Syndrome Triggered by Overuse of Caffeine and Complicated With Neuroleptic Malignant Syndrome: A Case Report. Cureus. vol 14. issue 2. 2022-03-29. PMID:35345760. |
patients with depression and parkinson's syndrome should be evaluated for associated comorbidities, particularly serotonin syndrome and neuroleptic malignant syndrome. |
2022-03-29 |
2023-08-13 |
Not clear |
| Meghan Viveiro. Serotonin and neuroleptic malignant syndromes. JAAPA : official journal of the American Academy of Physician Assistants. vol 34. issue 3. 2021-11-24. PMID:33600112. |
serotonin and neuroleptic malignant syndromes. |
2021-11-24 |
2023-08-13 |
Not clear |
| N Kruijt, L R van den Bersselaar, J Wijma, W Verbeeck, M J H Coenen, J Neville, M Snoeck, E J Kamsteeg, H Jungbluth, C Kramers, N C Voerman. HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review. Neuromuscular disorders : NMD. vol 30. issue 12. 2021-10-14. PMID:33250373. |
neuroleptic malignant syndrome and serotonin syndrome are two syndromes whose molecular bases remain poorly understood. |
2021-10-14 |
2023-08-13 |
Not clear |
| N Kruijt, L R van den Bersselaar, J Wijma, W Verbeeck, M J H Coenen, J Neville, M Snoeck, E J Kamsteeg, H Jungbluth, C Kramers, N C Voerman. HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review. Neuromuscular disorders : NMD. vol 30. issue 12. 2021-10-14. PMID:33250373. |
this review underlines that a subset of patients with neuroleptic malignant syndrome and serotonin syndrome develop recurrent episodes of rhabdomyolysis. |
2021-10-14 |
2023-08-13 |
Not clear |
| N Kruijt, L R van den Bersselaar, J Wijma, W Verbeeck, M J H Coenen, J Neville, M Snoeck, E J Kamsteeg, H Jungbluth, C Kramers, N C Voerman. HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review. Neuromuscular disorders : NMD. vol 30. issue 12. 2021-10-14. PMID:33250373. |
however, the genetic background of neuroleptic malignant syndrome and serotonin syndrome has only been investigated to a very limited degree so far. |
2021-10-14 |
2023-08-13 |
Not clear |